GGrantIndex
← Leaderboards

Joan Reibman

New York University School Of Medicine

Google Scholar ↗PubMed ↗ORCID ↗
$39,766,410
Attributed
$42,849,786
Total exposure
37
Grants
19
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $10.4M · FY2005–25
$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

CDC$38,081,222 · 6
NIH$4,768,564 · 31

By mechanism

E11$30,000,000 · 1
U01$8,081,222 · 4
R01$3,408,882 · 1
T32$721,425 · 1
M01$638,257 · 29
U10$0 · 1

Top collaborators

Most similar at New York University School Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Asthma”

Research focus

AsthmaClinical ResearchHuman SubjectDendritic CellsRespiratory EpitheliumResearch PersonnelColony Stimulating FactorCytokineHuman Therapy EvaluationClinical TrialsRespiratory Disorder ChemotherapyComputer Retrieval Of Information On Scientific Projects DatabaseResourcesGrantSourceTissue /Cell CultureParticleUnited States National Institutes Of HealthFundingInstitutionBronchoscopyBloodCellular PathologyEpithelial Cells

Grant awards (79)

Cognitive decline among WTC survivors with chronic mental and physical disorders$599,959
U01 · FY2025 · OH
Complex WTC Exposures Impacting Persistent Large and Small Airflow Limitation and Vulnerable Subgroups in the WTC Survivor Population$499,993
U01 · FY2025 · OH
Cognitive decline among WTC survivors with chronic mental and physical disorders$599,945
U01 · FY2024 · OH
Complex WTC Exposures Impacting Persistent Large and Small Airflow Limitation and Vulnerable Subgroups in the WTC Survivor Population$491,306
U01 · FY2024 · OH
Cognitive decline among WTC survivors with chronic mental and physical disorders$599,950
U01 · FY2023 · OH
Complex WTC Exposures Impacting Persistent Large and Small Airflow Limitation and Vulnerable Subgroups in the WTC Survivor Population$499,064
U01 · FY2023 · OH
Cognitive decline among WTC survivors with chronic mental and physical disorders$599,949
U01 · FY2022 · OH
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust$499,959
U01 · FY2018 · OH
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust$500,000
U01 · FY2017 · OH
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust$476,693
U01 · FY2016 · OH
Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program$898,281
U01 · FY2015 · OH · contact PI
Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program$894,044
U01 · FY2014 · OH · contact PI
Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program$587,429
U01 · FY2013 · OH · contact PI
Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program$334,650
U01 · FY2013 · OH · contact PI
Diesel Exhaust Particles and Mucosal Immunity$345,960
R01 · FY2011 · ES · contact PI
WORLD TRADE CENTER NON-RESPONDER PROGRAM NEW YORK CITY HEALTH AND HOSPITALS CORPO$10,000,000
E11 · FY2010 · OH · contact PI
Diesel Exhaust Particles and Mucosal Immunity$349,455
R01 · FY2010 · ES · contact PI
WORLD TRADE CENTER NON-RESPONDER PROGRAM NEW YORK CITY HEALTH AND HOSPITALS CORPO$10,000,000
E11 · FY2009 · OH · contact PI
Diesel Exhaust Particles and Mucosal Immunity$352,984
R01 · FY2009 · ES · contact PI
WORLD TRADE CENTER NON-RESPONDER PROGRAM NEW YORK CITY HEALTH AND HOSPITALS CORPO$10,000,000
E11 · FY2008 · OH · contact PI
Diesel Exhaust Particles and Mucosal Immunity$352,463
R01 · FY2008 · ES · contact PI
DISEASE MODIFYING GENES IN SEVERE ASTHMA$4,739
M01 · FY2008 · RR · contact PI
STUDY OF ACID REFLUX ASTHMA (SARA)$677
M01 · FY2008 · RR · contact PI
BLOOD-DERIVED DENDRITIC CELLS AND EPITHELIAL CELLS$677
M01 · FY2008 · RR · contact PI
BRONCHOALVEOLAR LAVAGE AND BRUSHINGS IN NORMALS$271
M01 · FY2008 · RR · contact PI
Diesel Exhaust Particles and Mucosal Immunity$359,125
R01 · FY2007 · ES · contact PI
DISEASE MODIFYING GENES IN SEVERE ASTHMA$16,175
M01 · FY2007 · RR · contact PI
BRONCHOALVEOLAR LAVAGE AND BRUSHINGS IN NORMALS$8,285
M01 · FY2007 · RR · contact PI
STUDY OF ACID REFLUX ASTHMA (SARA)$7,891
M01 · FY2007 · RR · contact PI
AMBIENT PARTICULATE MATTER AND HUMAN BRONCHIAL EPITHELIAL CELLS$1,578
M01 · FY2007 · RR · contact PI
BLOOD-DERIVED DENDRITIC CELLS AND EPITHELIAL CELLS$1,184
M01 · FY2007 · RR · contact PI
DISEASE MODIFYING GENES IN SEVERE ASTHMA$23,848
M01 · FY2006 · RR · contact PI
BRONCHOALVEOLAR LAVAGE AND BRUSHINGS IN NORMALS$22,446
M01 · FY2006 · RR · contact PI
STUDY OF ACID REFLUX ASTHMA (SARA)$20,576
M01 · FY2006 · RR · contact PI
AMBIENT PARTICULATE MATTER AND HUMAN BRONCHIAL EPITHELIAL CELLS$11,223
M01 · FY2006 · RR · contact PI
EFFECT OF EDUCATION AND DRUG PRESENTATION ON EFFICACY OF MONTELUKAST IN ASTHMA$2,806
M01 · FY2006 · RR · contact PI
BLOOD-DERIVED DENDRITIC CELLS AND EPITHELIAL CELLS$936
M01 · FY2006 · RR · contact PI
THE LEUKOTRIENE MODIFIER OR CORTICOSTEROID OR CORTICOSTEROID-SALMETEROL TRIAL$467
M01 · FY2006 · RR · contact PI
Ambient Particulate Matter and Epithelial Cells$330,000
R01 · FY2005 · ES
DISEASE MODIFYING GENES IN SEVERE ASTHMA$100,742
M01 · FY2005 · RR
NYU WORLD TRADE CENTER RESPONDER HEALTH CONSORTIUM PROTOCOL$79,735
M01 · FY2005 · RR
THE LEUKOTRIENE MODIFIER OR CORTICOSTEROID OR CORTICOSTEROID-SALMETEROL TRIAL$39,151
M01 · FY2005 · RR
AMBIENT PARTICULATE MATTER AND HUMAN BRONCHIAL EPITHELIAL CELLS$20,053
M01 · FY2005 · RR
BLOOD-DERIVED DENDRITIC CELLS AND EPITHELIAL CELLS$8,594
M01 · FY2005 · RR
EFFECT OF EDUCATION AND DRUG PRESENTATION ON EFFICACY OF MONTELUKAST IN ASTHMA$2,388
M01 · FY2005 · RR
Molecular and Cell Biology in Environmental Medicine$349,783
T32 · FY2004 · ES
Ambient Particulate Matter and Epithelial Cells$330,000
R01 · FY2004 · ES
Disease Modifying Genes in Severe Asthma$141,255
M01 · FY2004 · RR
Ambient Particulate Matter and Human Bronchial Epitheli$8,638
M01 · FY2004 · RR
Leukotriene Modifier or Corticosteroid or Corticosteroid$6,097
M01 · FY2004 · RR
Low Dose Theophylline as Add-On Therapy in the Treatment of Asthma$2,033
M01 · FY2004 · RR
Blood-Derived Dendritic Cells and Epithelial Cells$762
M01 · FY2004 · RR
NYU World Trade Center Responder Health Consortium$0
U10 · FY2004 · OH
Molecular and Cell Biology in Environmental Medicine$371,642
T32 · FY2003 · ES
Ambient Particulate Matter and Epithelial Cells$330,000
R01 · FY2003 · ES
Ambient Particulate Matter and Epithelial Cells$330,000
R01 · FY2002 · ES
EXTENSION OF MK-0476 (#701)--LONG TERM SAFETY &TOLERABILITY IN CHRONIC ASTHMA$0
M01 · FY2002 · RR
REGULATION OF GM CSF IN AIRWAY EPITHELIAL CELLS$0
M01 · FY2002 · RR
AMBIENT AIR POLLUTION AND ASTHMA$0
M01 · FY2002 · RR
AEROBID-M WITH AND WITHOUT AEROCHAMBER IN MILD-MODERATE ASTHMA$0
M01 · FY2002 · RR
REGULATION OF MOLECULES BY TUBERCULOSIS$0
M01 · FY2002 · RR
Ambient Particulate Matter and Epithelial Cells$328,895
R01 · FY2001 · ES
REGULATION OF MOLECULES BY TUBERCULOSIS$0
M01 · FY2001 · RR
REGULATION OF GM CSF IN AIRWAY EPITHELIAL CELLS$0
M01 · FY2001 · RR
AMBIENT AIR POLLUTION AND ASTHMA$0
M01 · FY2001 · RR
AEROBID-M WITH AND WITHOUT AEROCHAMBER IN MILD-MODERATE ASTHMA$0
M01 · FY2001 · RR
EXTENSION OF MK-0476 (#701)--LONG TERM SAFETY &TOLERABILITY IN CHRONIC ASTHMA$0
M01 · FY2001 · RR
EXTENSION OF MK-0476 (#701)--LONG TERM SAFETY &TOLERABILITY IN CHRONIC ASTHMA$21,006
M01 · FY2000 · RR
REGULATION OF GM CSF IN AIRWAY EPITHELIAL CELLS$21,006
M01 · FY2000 · RR
AMBIENT AIR POLLUTION AND ASTHMA$21,006
M01 · FY2000 · RR
AEROBID-M WITH AND WITHOUT AEROCHAMBER IN MILD-MODERATE ASTHMA$21,006
M01 · FY2000 · RR
REGULATION OF MOLECULES BY TUBERCULOSIS$21,006
M01 · FY2000 · RR
AMBIENT AIR POLLUTION AND ASTHMA$0
M01 · FY2000 · RR
REGULATION OF MOLECULES BY TUBERCULOSIS$0
M01 · FY2000 · RR
EXTENSION OF MK-0476 (#701)--LONG TERM SAFETY &TOLERABILITY IN CHRONIC ASTHMA$0
M01 · FY2000 · RR
INTRAEPITHELIAL CELLS IN THE ASTHMATIC AIRWAY$0
M01 · FY2000 · RR
INTRAEPITHELIAL CELLS IN THE ASTHMATIC AIRWAY$0
M01 · FY2000 · RR
REGULATION OF GM CSF IN AIRWAY EPITHELIAL CELLS$0
M01 · FY2000 · RR
AEROBID-M WITH AND WITHOUT AEROCHAMBER IN MILD-MODERATE ASTHMA$0
M01 · FY2000 · RR